Morton Capital Management LLC/CA

Position in GILD — Gilead Sciences, Inc.

CIK 2002628 CALABASAS, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$237,898

-$14,640 QoQ

Shares Held

1,883

+3.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#1,814

of 2,266 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Morton Capital Management LLC/CA holds $8,598,595 across 6 Drug Manufacturers - General names. GILD ranks #6 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	9,961	$2,506,586
2	AMGN	Amgen Inc	6,352	$2,300,186
3	JNJ	Johnson & Johnson	5,909	$1,500,708
4	LLY	ELI LILLY & Co	905	$1,085,484
5	MRK	Merck & Co., Inc.	7,531	$967,733
6	GILD	Gilead Sciences, Inc. This page	1,883	$237,898

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$237,898	1,883	+3.9%	Shares	Sole	2026-07-23
2026-03-31	$252,538	1,812	+9.0%	Shares	Sole	2026-04-21
2025-12-31	$204,116	1,663	—	Shares	Sole	2026-02-03
No filing history on record for this holder in this stock.